Mul1 and Park are two major mitochondrial ligases responsible for mitophagy. Damaged mitochondria that cannot be removed are a source of an increased level of free radicals, which in turn can destructively affect other cell organelles as well as entire cells. One of the toxins that damages mitochondria is rotenone, a neurotoxin that after exposure displays symptoms typical of Parkinson’s disease. In the present study, we showed that overexpressing genes encoding mitochondrial ligases protects neurons during treatment with rotenone. Drosophila strains with overexpressed mul1 or park show a significantly reduced degeneration of dopaminergic neurons, as well as normal motor activity during exposure to rotenone. In the nervous system, rotenone ...
Current treatments for Parkinson’s disease (PD) only alleviate symptoms doing little to inhibi...
Mitochondria act as the powerhouse of eukaryotic cells. These organelles are ultimately able to con...
a b s t r a c t Current treatment options for parkinsonism as a neurodegenerative disease are limite...
The accumulation of dysfunctional or damaged mitochondria in neurons has been linked to the pathogen...
peer reviewedNew discoveries providing insights into mitochondrial bioenergetics, their dynamic inte...
Parkinson’s disease (PD) is the most common neurodegenerative movement disorder. Despite recent adva...
Parkinson disease (PD) is the second most common neurodegenerative disorder and is strongly associa...
Parkinson’s disease (PD), caused by selective loss of dopaminergic (DAergic) neurons in the substant...
Parkinson's disease (PD) is a neurodegenerative disease with motor symptoms as well as non-motor sym...
The loss of dopaminergic (DA) neurons in the substantia nigra leads to a progressive, long-term decl...
<div><p>The pesticide rotenone, a neurotoxin that inhibits the mitochondrial complex I, and destabil...
The selective loss of a particular subset of neurons is a common feature of neurodegenerative diso...
The pesticide rotenone, a neurotoxin that inhibits the mitochondrial complex I, and destabilizes mic...
Parkinson's disease (PD) is a common degenerative disease of the nervous system. The pathogenesis of...
The accumulation of dysfunctional or damaged mitochondria in neurons has been linked to the pathogen...
Current treatments for Parkinson’s disease (PD) only alleviate symptoms doing little to inhibi...
Mitochondria act as the powerhouse of eukaryotic cells. These organelles are ultimately able to con...
a b s t r a c t Current treatment options for parkinsonism as a neurodegenerative disease are limite...
The accumulation of dysfunctional or damaged mitochondria in neurons has been linked to the pathogen...
peer reviewedNew discoveries providing insights into mitochondrial bioenergetics, their dynamic inte...
Parkinson’s disease (PD) is the most common neurodegenerative movement disorder. Despite recent adva...
Parkinson disease (PD) is the second most common neurodegenerative disorder and is strongly associa...
Parkinson’s disease (PD), caused by selective loss of dopaminergic (DAergic) neurons in the substant...
Parkinson's disease (PD) is a neurodegenerative disease with motor symptoms as well as non-motor sym...
The loss of dopaminergic (DA) neurons in the substantia nigra leads to a progressive, long-term decl...
<div><p>The pesticide rotenone, a neurotoxin that inhibits the mitochondrial complex I, and destabil...
The selective loss of a particular subset of neurons is a common feature of neurodegenerative diso...
The pesticide rotenone, a neurotoxin that inhibits the mitochondrial complex I, and destabilizes mic...
Parkinson's disease (PD) is a common degenerative disease of the nervous system. The pathogenesis of...
The accumulation of dysfunctional or damaged mitochondria in neurons has been linked to the pathogen...
Current treatments for Parkinson’s disease (PD) only alleviate symptoms doing little to inhibi...
Mitochondria act as the powerhouse of eukaryotic cells. These organelles are ultimately able to con...
a b s t r a c t Current treatment options for parkinsonism as a neurodegenerative disease are limite...